VFC's Stock House

Cell Therapeutics Could Be a Real Winner, But Not Right Now

Thanks for the comments, all. Much appreciated.

User 478153, I think your points are valid and understood by many investors, but you're assuming approval. With a market cap of near one billion, it's hard to invest based on an FDA decision, because if the FDA asks for more data, then investors are looking at a 50% price cut overnight. At least. That's a big drop.

I see both arguments, but I wouldn't go "all in" on CTIC.

Thanks again, I appreciate all comments - especially when we 'keep it real.'

VFC